Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Subst Abuse Treat. 2004 Apr;26(3):225-32.

Cost effectiveness of disulfiram: treating cocaine use in methadone-maintained patients.

Author information

  • 1ICEH-London School of Hygiene and Tropical Medicine, Keppel Street, Room 9/311, London WC1E 7HT, UK. mireia.jofre-bonet@lshtm.ac.uk

Abstract

Converging evidence suggests that disulfiram is a promising treatment for cocaine dependence. We study the cost-effectiveness of providing disulfiram to methadone-maintained opioid addicts in a randomized clinical trial setting. Our economic evaluation is based on a double blind clinical trial in which 67 cocaine-dependent methadone-maintained opioid-dependent subjects were randomized to get the additional treatment of disulfiram or placebo in a 12-week trial. Outcome measures used are the number of days of cocaine use and grams of cocaine per week. Cost measures used are the cost of providing standard methadone treatment and the incremental cost of adding disulfiram to the standard treatment. Cost measures of standard and disulfiram-enhanced treatment were collected retrospectively from the provider. Results from this cost-effectiveness analysis imply that, even though disulfiram increases slightly the cost of methadone treatment, its increase in effectiveness may be important enough to warrant its addition for treating cocaine dependence in methadone-maintained opiate addicts.

PMID:
15063917
[PubMed - indexed for MEDLINE]
PMCID:
PMC3662046
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk